APO Research
Talk to an analyst

APO RESEARCH · REPORT

Single B Cell Antibody Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Single B Cell Antibody Service Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchSingle B Cell Antibody Service Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Single B Cell Antibody Service Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Single B Cell Antibody Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Single B Cell Antibody Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Single B Cell Antibody Service Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Single B Cell Antibody Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Single B Cell Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Single B Cell Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Single B Cell Antibody Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Single B Cell Antibody Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Single B Cell Antibody Service market include GenScript, Sino Biological, Inc, ProteoGenix, Biointron, Creative Biolabs, ACROBiosystems, Sydlabs, Cusabio and Medicilon, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Single B Cell Antibody Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Single B Cell Antibody Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Single B Cell Antibody Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Single B Cell Antibody Service market.

Single B Cell Antibody Service Segment by Company

GenScript

Sino Biological, Inc

ProteoGenix

Biointron

Creative Biolabs

ACROBiosystems

Sydlabs

Cusabio

Medicilon

Creative Diagnostics

ProBio

Genovac

Active Motif

Single B Cell Antibody Service Segment by Type

Hybridoma Technology

Phage Display Technology

Others

Single B Cell Antibody Service Segment by Application

Biomedical Research

Diagnostics

Other

Single B Cell Antibody Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Single B Cell Antibody Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Single B Cell Antibody Service key companies, revenue, market share, and recent developments.

3. To split the Single B Cell Antibody Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Single B Cell Antibody Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Single B Cell Antibody Service significant trends, drivers, influence factors in global and regions.

6. To analyze Single B Cell Antibody Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Single B Cell Antibody Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Single B Cell Antibody Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Single B Cell Antibody Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Single B Cell Antibody Service industry.

Chapter 3: Detailed analysis of Single B Cell Antibody Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Single B Cell Antibody Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Single B Cell Antibody Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Single B Cell Antibody Service Industry Trends Table 2. Single B Cell Antibody Service Industry Drivers Table 3. Single B Cell Antibody Service Industry Opportunities and Challenges Table 4. Single B Cell Antibody Service Industry Restraints Table 5. Global Single B Cell Antibody Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Single B Cell Antibody Service Revenue Share by Company (2021-2026) Table 7. Global Single B Cell Antibody Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Single B Cell Antibody Service Key Company Manufacturing Base & Headquarters Table 9. Global Single B Cell Antibody Service Company, Product Type & Application Table 10. Global Single B Cell Antibody Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Single B Cell Antibody Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hybridoma Technology Table 15. Significant Companies of Phage Display Technology Table 16. Significant Companies of Others Table 17. Global Single B Cell Antibody Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Single B Cell Antibody Service Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Single B Cell Antibody Service Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Single B Cell Antibody Service Sales Value Share by Type (2021-2026) Table 21. Global Single B Cell Antibody Service Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Biomedical Research Table 23. Significant Companies of Diagnostics Table 24. Significant Companies of Other Table 25. Global Single B Cell Antibody Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Single B Cell Antibody Service Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Single B Cell Antibody Service Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Single B Cell Antibody Service Sales Value Share by Application (2021-2026) Table 29. Global Single B Cell Antibody Service Sales Value Share by Application (2027-2032) Table 30. Global Single B Cell Antibody Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Single B Cell Antibody Service Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Single B Cell Antibody Service Sales Value Share by Region (2021-2026) Table 33. Global Single B Cell Antibody Service Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Single B Cell Antibody Service Sales Value Share by Region (2027-2032) Table 35. Global Single B Cell Antibody Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Single B Cell Antibody Service Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Single B Cell Antibody Service Sales Value Market Share by Country (2021-2026) Table 38. Global Single B Cell Antibody Service Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Single B Cell Antibody Service Sales Value Market Share by Country (2027-2032) Table 40. GenScript Company Information Table 41. GenScript Business Overview Table 42. GenScript Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. GenScript Single B Cell Antibody Service Product Portfolio Table 44. GenScript Recent Development Table 45. Sino Biological, Inc Company Information Table 46. Sino Biological, Inc Business Overview Table 47. Sino Biological, Inc Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Sino Biological, Inc Single B Cell Antibody Service Product Portfolio Table 49. Sino Biological, Inc Recent Development Table 50. ProteoGenix Company Information Table 51. ProteoGenix Business Overview Table 52. ProteoGenix Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. ProteoGenix Single B Cell Antibody Service Product Portfolio Table 54. ProteoGenix Recent Development Table 55. Biointron Company Information Table 56. Biointron Business Overview Table 57. Biointron Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Biointron Single B Cell Antibody Service Product Portfolio Table 59. Biointron Recent Development Table 60. Creative Biolabs Company Information Table 61. Creative Biolabs Business Overview Table 62. Creative Biolabs Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Creative Biolabs Single B Cell Antibody Service Product Portfolio Table 64. Creative Biolabs Recent Development Table 65. ACROBiosystems Company Information Table 66. ACROBiosystems Business Overview Table 67. ACROBiosystems Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. ACROBiosystems Single B Cell Antibody Service Product Portfolio Table 69. ACROBiosystems Recent Development Table 70. Sydlabs Company Information Table 71. Sydlabs Business Overview Table 72. Sydlabs Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Sydlabs Single B Cell Antibody Service Product Portfolio Table 74. Sydlabs Recent Development Table 75. Cusabio Company Information Table 76. Cusabio Business Overview Table 77. Cusabio Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Cusabio Single B Cell Antibody Service Product Portfolio Table 79. Cusabio Recent Development Table 80. Medicilon Company Information Table 81. Medicilon Business Overview Table 82. Medicilon Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Medicilon Single B Cell Antibody Service Product Portfolio Table 84. Medicilon Recent Development Table 85. Creative Diagnostics Company Information Table 86. Creative Diagnostics Business Overview Table 87. Creative Diagnostics Single B Cell Antibody Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Creative Diagnostics Single B Cell Antibody Service Product Portfolio Table 89. Creative Diagnostics Recent Development Table 90. ProBio Company Information Table 91. ProBio Business Overview Table 92. ProBio Single B Cell Antibody Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. ProBio Single B Cell Antibody Service Product Portfolio Table 94. ProBio Recent Development Table 95. Genovac Company Information Table 96. Genovac Business Overview Table 97. Genovac Single B Cell Antibody Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Genovac Single B Cell Antibody Service Product Portfolio Table 99. Genovac Recent Development Table 100. Active Motif Company Information Table 101. Active Motif Business Overview Table 102. Active Motif Single B Cell Antibody Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Active Motif Single B Cell Antibody Service Product Portfolio Table 104. Active Motif Recent Development Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Single B Cell Antibody Service Product Image Figure 2. Global Single B Cell Antibody Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Single B Cell Antibody Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Single B Cell Antibody Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hybridoma Technology Image Figure 8. Phage Display Technology Image Figure 9. Others Image Figure 10. Global Single B Cell Antibody Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Single B Cell Antibody Service Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Single B Cell Antibody Service Sales Value Share by Type (2021-2032) Figure 13. Biomedical Research Image Figure 14. Diagnostics Image Figure 15. Other Image Figure 16. Global Single B Cell Antibody Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Single B Cell Antibody Service Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Single B Cell Antibody Service Sales Value Share by Application (2021-2032) Figure 19. Global Single B Cell Antibody Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Single B Cell Antibody Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Single B Cell Antibody Service Sales Value (2021-2032) & (US$ Million) Figure 22. North America Single B Cell Antibody Service Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Single B Cell Antibody Service Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Single B Cell Antibody Service Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Single B Cell Antibody Service Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Single B Cell Antibody Service Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Single B Cell Antibody Service Sales Value (2021-2032) & (US$ Million) Figure 28. South America Single B Cell Antibody Service Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Single B Cell Antibody Service Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Single B Cell Antibody Service Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Single B Cell Antibody Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Hybridoma Technology
  • Phage Display Technology
  • Others
Applications
  • Biomedical Research
  • Diagnostics
  • Other
Companies covered
  • GenScript
  • Sino Biological, Inc
  • ProteoGenix
  • Biointron
  • Creative Biolabs
  • ACROBiosystems
  • Sydlabs
  • Cusabio
  • Medicilon
  • Creative Diagnostics
  • ProBio
  • Genovac
  • Active Motif

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Single B Cell Antibody Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Single B Cell Antibody Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Single B Cell Antibody Service Market Dynamics
  1. 2.1 Single B Cell Antibody Service Industry Trends
  2. 2.2 Single B Cell Antibody Service Industry Drivers
  3. 2.3 Single B Cell Antibody Service Industry Opportunities and Challenges
  4. 2.4 Single B Cell Antibody Service Industry Restraints
3 Single B Cell Antibody Service Market by Company
  1. 3.1 Global Single B Cell Antibody Service Company Revenue Ranking in 2025
  2. 3.2 Global Single B Cell Antibody Service Revenue by Company (2021-2026)
  3. 3.3 Global Single B Cell Antibody Service Company Ranking (2024-2026)
  4. 3.4 Global Single B Cell Antibody Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Single B Cell Antibody Service Company Product Type and Application
  6. 3.6 Global Single B Cell Antibody Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Single B Cell Antibody Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Single B Cell Antibody Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Single B Cell Antibody Service Market by Type
  1. 4.1 Single B Cell Antibody Service Type Introduction
  2. 4.1.1 Hybridoma Technology
  3. 4.1.2 Phage Display Technology
  4. 4.1.3 Others
  5. 4.2 Global Single B Cell Antibody Service Sales Value by Type
  6. 4.2.1 Global Single B Cell Antibody Service Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Single B Cell Antibody Service Sales Value by Type (2021-2032)
  8. 4.2.3 Global Single B Cell Antibody Service Sales Value Share by Type (2021-2032)
5 Single B Cell Antibody Service Market by Application
  1. 5.1 Single B Cell Antibody Service Application Introduction
  2. 5.1.1 Biomedical Research
  3. 5.1.2 Diagnostics
  4. 5.1.3 Other
  5. 5.2 Global Single B Cell Antibody Service Sales Value by Application
  6. 5.2.1 Global Single B Cell Antibody Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Single B Cell Antibody Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Single B Cell Antibody Service Sales Value Share by Application (2021-2032)
6 Single B Cell Antibody Service Regional Value Analysis
  1. 6.1 Global Single B Cell Antibody Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Single B Cell Antibody Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Single B Cell Antibody Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Single B Cell Antibody Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Single B Cell Antibody Service Sales Value (2021-2032)
  7. 6.3.2 North America Single B Cell Antibody Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Single B Cell Antibody Service Sales Value (2021-2032)
  10. 6.4.2 Europe Single B Cell Antibody Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Single B Cell Antibody Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Single B Cell Antibody Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Single B Cell Antibody Service Sales Value (2021-2032)
  16. 6.6.2 South America Single B Cell Antibody Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Single B Cell Antibody Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Single B Cell Antibody Service Sales Value Share by Country, 2025 VS 2032
7 Single B Cell Antibody Service Country-level Value Analysis
  1. 7.1 Global Single B Cell Antibody Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Single B Cell Antibody Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Single B Cell Antibody Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Single B Cell Antibody Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Single B Cell Antibody Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Single B Cell Antibody Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Single B Cell Antibody Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GenScript
  2. 8.1.1 GenScript Company Information
  3. 8.1.2 GenScript Business Overview
  4. 8.1.3 GenScript Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GenScript Single B Cell Antibody Service Product Portfolio
  6. 8.1.5 GenScript Recent Developments
  7. 8.2 Sino Biological, Inc
  8. 8.2.1 Sino Biological, Inc Company Information
  9. 8.2.2 Sino Biological, Inc Business Overview
  10. 8.2.3 Sino Biological, Inc Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sino Biological, Inc Single B Cell Antibody Service Product Portfolio
  12. 8.2.5 Sino Biological, Inc Recent Developments
  13. 8.3 ProteoGenix
  14. 8.3.1 ProteoGenix Company Information
  15. 8.3.2 ProteoGenix Business Overview
  16. 8.3.3 ProteoGenix Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ProteoGenix Single B Cell Antibody Service Product Portfolio
  18. 8.3.5 ProteoGenix Recent Developments
  19. 8.4 Biointron
  20. 8.4.1 Biointron Company Information
  21. 8.4.2 Biointron Business Overview
  22. 8.4.3 Biointron Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Biointron Single B Cell Antibody Service Product Portfolio
  24. 8.4.5 Biointron Recent Developments
  25. 8.5 Creative Biolabs
  26. 8.5.1 Creative Biolabs Company Information
  27. 8.5.2 Creative Biolabs Business Overview
  28. 8.5.3 Creative Biolabs Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biolabs Single B Cell Antibody Service Product Portfolio
  30. 8.5.5 Creative Biolabs Recent Developments
  31. 8.6 ACROBiosystems
  32. 8.6.1 ACROBiosystems Company Information
  33. 8.6.2 ACROBiosystems Business Overview
  34. 8.6.3 ACROBiosystems Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ACROBiosystems Single B Cell Antibody Service Product Portfolio
  36. 8.6.5 ACROBiosystems Recent Developments
  37. 8.7 Sydlabs
  38. 8.7.1 Sydlabs Company Information
  39. 8.7.2 Sydlabs Business Overview
  40. 8.7.3 Sydlabs Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sydlabs Single B Cell Antibody Service Product Portfolio
  42. 8.7.5 Sydlabs Recent Developments
  43. 8.8 Cusabio
  44. 8.8.1 Cusabio Company Information
  45. 8.8.2 Cusabio Business Overview
  46. 8.8.3 Cusabio Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cusabio Single B Cell Antibody Service Product Portfolio
  48. 8.8.5 Cusabio Recent Developments
  49. 8.9 Medicilon
  50. 8.9.1 Medicilon Company Information
  51. 8.9.2 Medicilon Business Overview
  52. 8.9.3 Medicilon Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medicilon Single B Cell Antibody Service Product Portfolio
  54. 8.9.5 Medicilon Recent Developments
  55. 8.10 Creative Diagnostics
  56. 8.10.1 Creative Diagnostics Company Information
  57. 8.10.2 Creative Diagnostics Business Overview
  58. 8.10.3 Creative Diagnostics Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Creative Diagnostics Single B Cell Antibody Service Product Portfolio
  60. 8.10.5 Creative Diagnostics Recent Developments
  61. 8.11 ProBio
  62. 8.11.1 ProBio Company Information
  63. 8.11.2 ProBio Business Overview
  64. 8.11.3 ProBio Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ProBio Single B Cell Antibody Service Product Portfolio
  66. 8.11.5 ProBio Recent Developments
  67. 8.12 Genovac
  68. 8.12.1 Genovac Company Information
  69. 8.12.2 Genovac Business Overview
  70. 8.12.3 Genovac Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genovac Single B Cell Antibody Service Product Portfolio
  72. 8.12.5 Genovac Recent Developments
  73. 8.13 Active Motif
  74. 8.13.1 Active Motif Company Information
  75. 8.13.2 Active Motif Business Overview
  76. 8.13.3 Active Motif Single B Cell Antibody Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Active Motif Single B Cell Antibody Service Product Portfolio
  78. 8.13.5 Active Motif Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst